Immunobiology of Uveal Melanoma: State of the Art and Therapeutic Targets
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Immunobiology of Uveal Melanoma: State of the Art and Therapeutic Targets
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 9, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2019-11-05
DOI
10.3389/fonc.2019.01145
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Tumor mutational load predicts survival after immunotherapy across multiple cancer types
- (2019) Robert M. Samstein et al. NATURE GENETICS
- Differential modulation and prognostic values of immune-escape genes in uveal melanoma
- (2019) Maria Sofia Basile et al. PLoS One
- Adjuvant Ipilimumab in High-Risk Uveal Melanoma
- (2019) Eric Fountain et al. Cancers
- Immunomodulatory roles of nitric oxide in cancer: tumour microenvironment says “NO” to anti-tumour immune response
- (2019) Jon Peñarando et al. Translational Research
- Lopinavir-NO, a nitric oxide-releasing HIV protease inhibitor, suppresses the growth of melanoma cells in vitro and in vivo
- (2019) Svetlana Paskas et al. INVESTIGATIONAL NEW DRUGS
- Natural killer cells and pigment epithelial-derived factor control the infiltrative and nodular growth of hepatic metastases in an Orthotopic murine model of ocular melanoma
- (2019) Nyasia M. Jones et al. BMC CANCER
- Transforming Growth Factor-β Signaling in Immunity and Cancer
- (2019) Eduard Batlle et al. IMMUNITY
- Senescence as a main mechanism of Ritonavir and Ritonavir‐NO action against melanoma
- (2019) Svetlana Paskaš et al. MOLECULAR CARCINOGENESIS
- Role of Macrophage Migration Inhibitory Factor (MIF) in Melanoma
- (2019) Laura Soumoy et al. Cancers
- Pembrolizumab as first-line treatment for metastatic uveal melanoma
- (2019) Ernesto Rossi et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Transforming growth factor β signaling pathway: A promising therapeutic target for cancer
- (2019) Yuhong Chen et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Characterization of the Pathophysiological Role of CD47 in Uveal Melanoma
- (2019) Maria Cristina Petralia et al. MOLECULES
- Prognostic Value of Inducible Nitric Oxide Synthase (iNOS) in Human Cancer: A Systematic Review and Meta-Analysis
- (2019) Wenbiao Liao et al. Biomed Research International
- Immune microenvironment modulation unmasks therapeutic benefit of radiotherapy and checkpoint inhibition
- (2019) Jared M. Newton et al. Journal for ImmunoTherapy of Cancer
- Hydrogen Gas in Cancer Treatment
- (2019) Sai Li et al. Frontiers in Oncology
- Prognostic value of DcR3 in solid tumors: A meta-analysis
- (2018) Hua Ge et al. CLINICA CHIMICA ACTA
- Nitric oxide donors for prostate and bladder cancers: Current state and challenges
- (2018) Amedea B. Seabra et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Gasotransmitters and the immune system: Mode of action and novel therapeutic targets
- (2018) Paolo Fagone et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Recent breakthroughs in metastatic uveal melanoma: a cause for optimism?
- (2018) Joseph J Sacco et al. Future Oncology
- Contribution of the macrophage migration inhibitory factor superfamily of cytokines in the pathogenesis of preclinical and human multiple sclerosis: In silico and in vivo evidences
- (2018) Paolo Fagone et al. JOURNAL OF NEUROIMMUNOLOGY
- Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma
- (2018) Alexander M.M. Eggermont et al. NEW ENGLAND JOURNAL OF MEDICINE
- Overexpression of macrophage migration inhibitory factor and functionally‑related genes, D‑DT, CD74, CD44, CXCR2 and CXCR4, in glioblastoma
- (2018) Mario Presti et al. Oncology Letters
- Induction of anergic or regulatory tumor-specific CD4+ T cells in the tumor-draining lymph node
- (2018) Ruby Alonso et al. Nature Communications
- Pathogenic role for macrophage migration inhibitory factor in glioblastoma and its targeting with specific inhibitors as novel tailored therapeutic approach
- (2018) Katia Mangano et al. Oncotarget
- Galectin-9 Expression Predicts Favorable Clinical Outcome in Solid Tumors: A Systematic Review and Meta-Analysis
- (2018) Xiaoxiang Zhou et al. Frontiers in Physiology
- Immune Privilege and Eye-Derived T-Regulatory Cells
- (2018) Hiroshi Keino et al. Journal of Immunology Research
- Prognostic significance of CD47 in human malignancies: a systematic review and meta-analysis
- (2018) Hui-Jun Zhao et al. Translational Cancer Research
- Metastatic uveal melanoma showing durable response to anti-CTLA-4 and anti-PD-1 combination therapy after experiencing progression on anti-PD-1 therapy alone
- (2018) Muhammad Zubair Afzal et al. Journal for ImmunoTherapy of Cancer
- Abstract 3805: Expression of tryptophan -2, 3-dioxygense (TDO) in metastatic uveal melanoma
- (2018) Mizue Terai et al. CANCER RESEARCH
- Targeting the IDO1 pathway in cancer: from bench to bedside
- (2018) Ming Liu et al. Journal of Hematology & Oncology
- Combined Effects of Yttrium-90 Transarterial Radioembolization around Immunotherapy for Hepatic Metastases from Uveal Melanoma: A Preliminary Retrospective Case Series
- (2018) Jiahe Zheng et al. JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY
- Anticancer and Differentiation Properties of the Nitric Oxide Derivative of Lopinavir in Human Glioblastoma Cells
- (2018) Maria Basile et al. MOLECULES
- Combined analysis of antigen presentation and T cell recognition reveals restricted immune responses in melanoma
- (2018) Shelly Kalaora et al. Cancer Discovery
- 1127OA personal neoantigen vaccine, NEO-PV-01, with anti-PD1 induces broad de novo anti-tumor immunity in patients with metastatic melanoma, NSCLC, and bladder cancer
- (2018) P A Ott et al. ANNALS OF ONCOLOGY
- 1247PDPhase II multicenter, single arm, open label study of nivolumab in combination with ipilimumab in untreated patients with metastatic uveal melanoma (GEM1402.NCT02626962)
- (2018) J M Piulats Rodriguez et al. ANNALS OF ONCOLOGY
- Role of MIF and D-DT in immune-inflammatory, autoimmune, and chronic respiratory diseases: from pathogenic factors to therapeutic targets
- (2018) Sven Günther et al. DRUG DISCOVERY TODAY
- Immune cells in the retina and choroid: Two different tissue environments that require different defenses and surveillance
- (2018) Paul G. McMenamin et al. PROGRESS IN RETINAL AND EYE RESEARCH
- Efficacy of Immunotherapy in Patients with Metastatic Mucosal or Uveal Melanoma
- (2018) Claire Mignard et al. Journal of Oncology
- Focus on cutaneous and uveal melanoma specificities
- (2017) Charlotte Pandiani et al. GENES & DEVELOPMENT
- Role of macrophage migration inhibitory factor in head and neck cancer and novel therapeutic targets: A systematic review
- (2017) Jérôme R. Lechien et al. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
- Inflammatory cell infiltrates in advanced metastatic uveal melanoma
- (2017) Yamini Krishna et al. HUMAN PATHOLOGY
- The CD47-SIRPα signaling axis as an innate immune checkpoint in cancer
- (2017) Hanke L. Matlung et al. IMMUNOLOGICAL REVIEWS
- TGF-β engineered mesenchymal stem cells (TGF-β/MSCs) for treatment of Type 1 diabetes (T1D) mice model
- (2017) Saeed Daneshmandi et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Melanoma subtypes demonstrate distinct PD-L1 expression profiles
- (2017) Genevieve J Kaunitz et al. LABORATORY INVESTIGATION
- Treatment of metastatic uveal melanoma with adoptive transfer of tumour-infiltrating lymphocytes: a single-centre, two-stage, single-arm, phase 2 study
- (2017) Smita S Chandran et al. LANCET ONCOLOGY
- Systematic genomic and translational efficiency studies of uveal melanoma
- (2017) Chelsea Place Johnson et al. PLoS One
- Liver-Resident NK Cells: The Human Factor
- (2017) Victoria Male TRENDS IN IMMUNOLOGY
- Identification of novel chemotherapeutic strategies for metastatic uveal melanoma
- (2017) Paolo Fagone et al. Scientific Reports
- Clinical outcomes in metastatic uveal melanoma treated with PD-1 and PD-L1 antibodies
- (2016) Alain P. Algazi et al. CANCER
- Prolonged Survival in Stage III Melanoma with Ipilimumab Adjuvant Therapy
- (2016) Alexander M.M. Eggermont et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nitric oxide signaling in human ovarian cancer: A potential therapeutic target
- (2016) Ahmed El-Sehemy et al. NITRIC OXIDE-BIOLOGY AND CHEMISTRY
- The innate immune receptor Dectin-2 mediates the phagocytosis of cancer cells by Kupffer cells for the suppression of liver metastasis
- (2016) Yoshitaka Kimura et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- In-depth proteomic profiling of the uveal melanoma secretome
- (2016) Martina Angi et al. Oncotarget
- Identification of an Immunogenic Subset of Metastatic Uveal Melanoma
- (2015) L. D. Rothermel et al. CLINICAL CANCER RESEARCH
- Reorienting the immune system in the treatment of cancer by using anti-PD-1 and anti-PD-L1 antibodies
- (2015) Troels H. Borch et al. DRUG DISCOVERY TODAY
- NKT cells act through third party bone marrow-derived cells to suppress NK cell activity in the liver and exacerbate hepatic melanoma metastases
- (2015) Leila Sadegh et al. INTERNATIONAL JOURNAL OF CANCER
- The NO-modified HIV protease inhibitor as a valuable drug for hematological malignancies: Role of p70S6K
- (2015) Danijela Maksimovic-Ivanic et al. LEUKEMIA RESEARCH
- A phase 2 study of tremelimumab in patients with advanced uveal melanoma
- (2015) Anthony M. Joshua et al. MELANOMA RESEARCH
- Tumour exosome integrins determine organotropic metastasis
- (2015) Ayuko Hoshino et al. NATURE
- Distribution of GNAQ and GNA11 Mutation Signatures in Uveal Melanoma Points to a Light Dependent Mutation Mechanism
- (2015) Mark J. de Lange et al. PLoS One
- Immunogenicity of somatic mutations in human gastrointestinal cancers
- (2015) E. Tran et al. SCIENCE
- Digital PCR Validates 8q Dosage as Prognostic Tool in Uveal Melanoma
- (2015) Mieke Versluis et al. PLoS One
- Macrophage migration inhibitory factor engages PI3K/Akt signalling and is a prognostic factor in metastatic melanoma
- (2014) Camila S Oliveira et al. BMC CANCER
- Efficacy and safety of ipilimumab in patients with pre-treated, uveal melanoma
- (2013) M. Maio et al. ANNALS OF ONCOLOGY
- Circulating immune cell and microRNA in patients with uveal melanoma developing metastatic disease
- (2013) Susan Achberger et al. MOLECULAR IMMUNOLOGY
- Signatures of mutational processes in human cancer
- (2013) Ludmil B. Alexandrov et al. NATURE
- Immune surveillance by the liver
- (2013) Craig N Jenne et al. NATURE IMMUNOLOGY
- Liver sinusoidal endothelial cells contribute to CD8 T cell tolerance toward circulating carcinoembryonic antigen in mice
- (2012) Bastian Höchst et al. HEPATOLOGY
- Influence of CD8+ T regulatory cells on intraocular tumor development
- (2012) Kyle C. McKenna et al. Frontiers in Immunology
- Good news–bad news: the Yin and Yang of immune privilege in the eye
- (2012) John V. Forrester et al. Frontiers in Immunology
- Ocular Immune Privilege and Ocular Melanoma: Parallel Universes or Immunological Plagiarism?
- (2012) Jerry Y. Niederkorn Frontiers in Immunology
- Intratumoral forkhead box P3-positive regulatory T cells predict poor survival in cyclooxygenase-2-positive uveal melanoma
- (2010) Dimitrios Mougiakakos et al. CANCER
- Uveoscleral outflow – A review
- (2009) Albert Alm et al. EXPERIMENTAL EYE RESEARCH
- Expression and prognostic significance of iNOS in uveal melanoma
- (2009) C. Christian Johansson et al. INTERNATIONAL JOURNAL OF CANCER
- CNS metastasis from malignant uveal melanoma: a clinical and histopathological characterisation
- (2008) S K Holfort et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Molecular Pathways Mediating Liver Metastasis in Patients with Uveal Melanoma
- (2008) S. Bakalian et al. CLINICAL CANCER RESEARCH
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started